geoscience.net logo
+ Resolve Article
+ Follow Us
Follow on FacebookFollow on Facebook
Follow on TwitterFollow on Twitter

+ Translate
+ Subscribe to Site Feed
GeoScience Most Shared ContentMost Shared Content

Optimum population-level use of artemisinin combination therapies: a modelling study


, : Optimum population-level use of artemisinin combination therapies: a modelling study. Lancet. Global Health 3(12): E758-E766

Artemisinin combination therapies (ACTs) are used worldwide as first-line treatment against confirmed or suspected Plasmodium falciparum malaria. Despite the success of ACTs at reducing the global burden of malaria, emerging resistance to artemisinin threatens these gains. Countering onset of resistance might need deliberate tactics aimed at slowing the reduction in ACT effectiveness. We assessed optimum use of ACTs at the population level, specifically focusing on a strategy of multiple first-line therapies (MFT), and comparing it with strategies of cycling or sequential use of single first-line ACTs. With an individual-based microsimulation of regional malaria transmission, we looked at how to apply a therapy as widely as possible without accelerating reduction of efficacy by drug resistance. We compared simultaneous distribution of artemether-lumefantrine, artesunate-amodiaquine, and dihydroartemisinin-piperaquine (ie, MFT) against strategies in which these ACTs would be cycled or used sequentially, either on a fixed schedule or when population-level efficacy reaches the WHO threshold of 10% treatment failure. The main assessment criterion was total number of treatment failures per 100 people per year. Additionally, we analysed the benefits of including a single non-ACT therapy in an MFT strategy, and did sensitivity analyses in which we varied transmission setting, treatment coverage, partner-drug half-life, fitness cost of drug resistance, and the relation between drug concentration and resistance evolution. Use of MFT was predicted to reduce the long-term number of treatment failures compared with strategies in which a single first-line ACT is recommended. This result was robust to various epidemiological, pharmacological, and evolutionary features of malaria transmission. Inclusion of a single non-ACT therapy in an MFT strategy would have substantial benefits in reduction of pressure on artemisinin resistance evolution, delaying its emergence and slowing its spread. Adjusting national antimalarial treatment guidelines to encourage simultaneous use of MFT is likely to extend the useful therapeutic life of available antimalarial drugs, resulting in long-term beneficial outcomes for patients. Wellcome Trust, UK Medical Research Council, Li Ka Shing Foundation.

US$19.90

PMID: 26545449

DOI: 10.1016/S2214-109X(15)00162-X


Other references

Levy, W.J.; Oro, J.J., 1984: Curved biopsy needle for stereotactic surgery: a technical note. Needle brain biopsy and aspiration is an important technique for the diagnosis of tumors and for the evacuation of fluid collections. Current biopsy methods use a straight needle, which has the disadvantage of requiring multiple passes through the...

Peucat J.J.; Mascarenhas J.F.; Barbosa J.S.F.; de Souza S.L.; Marinho M.M.; Fanning C.M.; Leite C.M.M., 2002: 33 Ga SHRIMP U-Pb zircon age of a felsic metavolcanic rock from the Mundo Novo greenstone belt in the Sao Francisco Craton, Bahia; northeastern Brazil. Felsic metavolcanics associated with supracrustal rocks provide U-Pb zircon and Sm-Nd T (sub DM) ages of approximately 3.3 Ga, which establish an Archean age of the Mundo Novo greenstone belt. A granodioritic gneiss from the Mairi complex, located...

Carneiro, R.G.; Moritz, M.P.; Monaco, A.P. do A.; Lima, A.C.C. de; Santiago, D.C., 2006: Reaction of oat cultivars to race 1 and 3 of Meloidogyne incognita and to M. paranaensis. Oats may be an economically viable alternative as a winter crop, or in crop successions with the objective of economic production in areas infested by nematodes. To identify resistance to races 1 and 3 of Meloidogyne incognita and to M. paranaensi...

Li, C.; Hirooka, Y.; Honda, R.; Morikawa, R.; Yatoh, M.; Gotoh, M.; Nogimori, T., 2005: Distribution of aquaporin-9 in the rat: an immunohistochemical study. The aim of this study was to identify the distribution of aquaporin-9 by immunohistochemistry in rat tissues using specific antipeptide antiserum which we recently produced. Anti-aquaporin-9 antibody was raised in New Zealand white rabbits immuniz...

D.Paula, A., 1958: Leanness; its elassification, etiopathogenesis, diagnosis & treatment. Revista Brasileira de Medicina 15(7): 496-498

Feldmann Rodney M.; Casadio Silvio; Aguirre Urreta Maria; Foland Kenneth A., 1997: Radiometric age and biotic affinities of decapod crustaceans from the Centinela Formation, southern Patagonia, Argentina. Abstracts with Programs - Geological Society of America 29(6): 405

Floch, M.H., 1985: Clinical use of high-fiber diets. Delaware Medical Journal 57(10): 643-4, 649-52

Ezra D.; Feuerstein G.; Ramwell P.W.; Hayes E.; Goldstein R.E., 1985: Effects of platelet activating factor on coronary hemodynamics and coronary venous plasma levels of thromboxane b 2 6 ketoprostaglandin f 1 alpha and leukotriene c 4 immunoreactivity in the intact domestic pig heart. Serneri, G G N Et Al (Ed ) Advances in Prostaglandin Thromboxane And Leukotriene Research, Vol 13 Platelets, Prostaglandins, And The Cardiovascular System; Meeting, Florence, Italy, Feb , 1984 Xxviii+393p Raven Press: New York, N Y , Usa Illus 19-22

Morey, L.C.; Hopwood, C.J.; Markowitz, J.C.; Gunderson, J.G.; Grilo, C.M.; McGlashan, T.H.; Shea, M.T.; Yen, S.; Sanislow, C.A.; Ansell, E.B.; Skodol, A.E., 2012: Comparison of alternative models for personality disorders, II: 6-, 8- and 10-year follow-up. Several conceptual models have been considered for the assessment of personality pathology in DSM-5. This study sought to extend our previous findings to compare the long-term predictive validity of three such models: the five-factor model (FFM),...

Li, R.W.; Wong, J.B., 1997: Postexposure treatment of HIV. This is a discussion of decision-analysis models relating to the potential public health costs of treating every exposure to HIV prophylactically with currently available drugs in response to an article by Katz M. H. & Gerberding, J. L. [New Engla...